@article {244405,
	title = {Protective efficacy of Toxoplasma gondii infected cells-derived exosomes against chronic murine toxoplasmosis.},
	journal = {Acta tropica},
	volume = {248},
	year = {2023},
	pages = {107041},
	abstract = {<p>Exosomes were isolated from T. gondii infected human hepatoblastoma cells using the exosome isolation kit and characterized by electron microscopy and Western blotting. Exosomes adsorbed to alum adjuvant were evaluated as a potential immunizing agent against murine chronic toxoplasmosis compared to excretory secretory antigens (ESA)-alum. Mice were immunized at days 1, 15 and 29. The levels of IgG, IFN-γ, IL-4 and IL-10, CD4 and CD8 T cells were determined using sandwich enzyme-linked immunosorbent assay (sandwich ELISA) at days 14, 28 and 56 of the experiment. Then mice were infected orally with 10 cysts of T. gondii. The protective efficacy of the antigens were evaluated by counting the brain cysts and measuring the aforementioned humoral and cellular parameters 60 days post infection. The results showed that alum increased the protective efficacy of the exosomes. Immunization with exosome-alum induced both humoral and mixed Th1/Th2 cellular immune responses. Exosome-alum gave higher levels of the humoral and cellular parameters, compared to ESA-alum. After challenge infection, exosome-alum significantly reduced the brain cyst burden by 75~\% while ESA-alum gave 42~\% reduction and evoked higher humoral and cellular immune responses. Therefore, the possibility of using T. gondii infected cells-derived exosome-alum as a vaccine is a new perspective in toxoplasmosis.</p>
},
	author = {Gihan M. Tawfeek and Abou-El-Naga, Iman F and Hassan, Eman Mohamed Elsayed and Dina Sabry and Meselhey, Rasha Abdallah and Younis, Salwa Sami}
}
